These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3087705)

  • 1. Antigen- and lectin-sensitized murine cytolytic T lymphocyte-precursors require both interleukin 2 and endogenously produced immune (gamma) interferon for their growth and differentiation into effector cells.
    Simon MM; Landolfo S; Diamantstein T; Hochgeschwender U
    Curr Top Microbiol Immunol; 1986; 126():173-85. PubMed ID: 3087705
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies to interferon-gamma inhibit interleukin 2-dependent induction of growth and maturation in lectin/antigen-reactive cytolytic T lymphocyte precursors.
    Simon MM; Hochgeschwender U; Brugger U; Landolfo S
    J Immunol; 1986 Apr; 136(8):2755-62. PubMed ID: 3082972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.
    Erard F; Corthesy P; Nabholz M; Lowenthal JW; Zaech P; Plaetinck G; MacDonald HR
    J Immunol; 1985 Mar; 134(3):1644-52. PubMed ID: 3871453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
    Hardt C; Diamantstein T; Wagner H
    Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of cytolytic cells by pure recombinant human interleukin 2.
    Devos R; Plaetinck G; Fiers W
    Eur J Immunol; 1984 Nov; 14(11):1057-60. PubMed ID: 6437845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 induces both, growth and maturation of lectin reactive Lyt-2+ but not Lyt-2-precursor cells and regulates the cytolytic potential of effector cells.
    Hochgeschwender U; Diamantstein T; Prester M; Nerz G; Simon MM
    Immunobiology; 1986 Apr; 171(3):274-301. PubMed ID: 3086217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cytotoxic lymphocyte precursors. II. The effect of interleukin-2 and interferon-gamma on the apparent specificity of effector cells.
    Skinner MA; Finberg RW; Ertl HC
    Cell Immunol; 1986 Jun; 100(1):239-46. PubMed ID: 3091261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes.
    Takai Y; Herrmann SH; Greenstein JL; Spitalny GL; Burakoff SJ
    J Immunol; 1986 Dec; 137(11):3494-500. PubMed ID: 3097123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of heat-stable antigen on tumor cells provides co-stimulation for tumor-specific T cell proliferation and cytotoxicity in mice.
    Wang YC; Zhu L; McHugh R; Sell KW; Selvaraj P
    Eur J Immunol; 1995 May; 25(5):1163-7. PubMed ID: 7774619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S; Whiteside TL; Moretta L; von Fliedner V
    J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lytic function by recombinant IL2 and antigen.
    Ochoa AC; Gromo G; Wee SL; Bach FH
    Curr Top Microbiol Immunol; 1986; 126():155-64. PubMed ID: 2941240
    [No Abstract]   [Full Text] [Related]  

  • 13. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells.
    Maraskovsky E; Chen WF; Shortman K
    J Immunol; 1989 Aug; 143(4):1210-4. PubMed ID: 2501391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
    Gullo CA; Esser MT; Fuller CL; Lam Braciale V
    J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of proliferative and cytotoxic responses in resting Lyt-2+ T cells with lectin and recombinant interleukin 2.
    Vohr HW; Hünig T
    Eur J Immunol; 1985 Apr; 15(4):332-7. PubMed ID: 3872800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytolytic T cell hybridomas. I. Interleukin 2-independent noncytolytic variants.
    Haas W; Kisielow P
    Eur J Immunol; 1985 Aug; 15(8):751-5. PubMed ID: 3928389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A; Poggi A; Pende D; Tripodi G; Orengo AM; Pella N; Augugliaro R; Bottino C; Ciccone E; Moretta L
    J Exp Med; 1991 Dec; 174(6):1393-8. PubMed ID: 1720808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of T cell proliferation and cytotoxicity by lymphokines.
    Männel DN; Falk W; Dröge W
    Lymphokine Res; 1985; 4(2):133-8. PubMed ID: 3923276
    [No Abstract]   [Full Text] [Related]  

  • 19. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
    Itoh K; Platsoucas CD; Balch CM
    J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes.
    Manjunath N; Shankar P; Wan J; Weninger W; Crowley MA; Hieshima K; Springer TA; Fan X; Shen H; Lieberman J; von Andrian UH
    J Clin Invest; 2001 Sep; 108(6):871-8. PubMed ID: 11560956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.